Sina J. Torabi
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Previous Organizations / Institutes
The organizations / institutes from the scholar's other articles in the past ten years
Research Subjects
Sina J. Torabi has a total of 157 co-authors. Here are the top co-authors by number of shared publications:
- Edward C. Kuan
Department of Otolaryngology–Head and Neck Surgery, University of California, Irvine, Orange, California, United States
15 shared publications - Benjamin L. Judson
Department of Surgery, Section of Otolaryngology, Head and Neck Surgery Yale University School of Medicine New Haven Connecticut USA
13 shared publications R. Peter Manes
Division of Otolaryngology, Department of Surgery, Yale School of Medicine, Yale University, New Haven, CT, USA
11 shared publications- David A. Kasle
Department of Surgery (Division of Otolaryngology), Yale University School of Medicine, New Haven, CT, USA
9 shared publications Fouad Chouairi
Medical Student, Department of Surgery, Yale University School of Medicine, New Haven, CT
9 shared publications- Michael Alperovich
Department of Surgery, Division of Plastic and Reconstructive Surgery, Yale School of Medicine, New Haven, CT
6 shared publications
Latest Publications
- Open Access
- 27 August 2025
- Published by SAGE Publications in Ear, Nose & Throat Journal
Health Economics for the Otolaryngologist
Background: There is growing evidence throughout medicine, including otolaryngology, that reimbursements have consistently been falling over the last 2 decades, which no obvious end in sight. Herein, we aim to educate otolaryngologists on the macro and microeconomic forces acting on health economics, detail the trends in reimbursements, and discuss how these trends affect providers and patients. Methods: A narrative review of changes in reimbursements and practice patterns within otolaryngology was performed. Results: Otolaryngology procedures have experienced as much as a multifactorial 50% decrease in inflation-adjusted Medicare reimbursement since 2000. On a macroeconomic level, the decline has been driven by the 1997 Balanced Budget Act, which threatened a decrease in conversion factor (the rate per relative value unit [RVU] physicians are paid) year-after-year (often blunted by congressional acts). On a microeconomic level, many otolaryngologic procedures have been targets for bundling and decreased RVUs, most notably rhinologic procedures in 2018. Decreasing reimbursements may be contributing to increasing procedural volume, increasing demand for ancillary sources of practice income (eg, in-office CT scans), and increasing private equity/large hospital practice buyout. These may expose patients to decreased quality of care. Conclusions: Otolaryngologic payments have been in continued decline for 2 decades, with potential important consequences for providers and patients. Awareness of the issues surrounding this key trend are vital.
- 27 August 2025
- Published by SAGE Publications in Ear, Nose & Throat Journal
Open AccessHealth Economics for the Otolaryngologist
Background: There is growing evidence throughout medicine, including otolaryngology, that reimbursements have consistently been falling over the last 2 decades, which no obvious end in sight. Herein, we aim to educate otolaryngologists on the macro and microeconomic forces acting on health economics, detail the trends in reimbursements, and discuss how these trends affect providers and patients. Methods: A narrative review of changes in reimbursements and practice patterns within otolaryngology was performed. Results: Otolaryngology procedures have experienced as much as a multifactorial 50% decrease in inflation-adjusted Medicare reimbursement since 2000. On a macroeconomic level, the decline has been driven by the 1997 Balanced Budget Act, which threatened a decrease in conversion factor (the rate per relative value unit [RVU] physicians are paid) year-after-year (often blunted by congressional acts). On a microeconomic level, many otolaryngologic procedures have been targets for bundling and decreased RVUs, most notably rhinologic procedures in 2018. Decreasing reimbursements may be contributing to increasing procedural volume, increasing demand for ancillary sources of practice income (eg, in-office CT scans), and increasing private equity/large hospital practice buyout. These may expose patients to decreased quality of care. Conclusions: Otolaryngologic payments have been in continued decline for 2 decades, with potential important consequences for providers and patients. Awareness of the issues surrounding this key trend are vital.
- 1 May 2025
- Published by SAGE Publications in Facial Plastic Surgery & Aesthetic Medicine
- Vol. 27 (3) , 237-238
The Bilateral Selective Neurectomy for Bilateral Synkinesis
- 1 May 2025
- Published by SAGE Publications in Facial Plastic Surgery & Aesthetic Medicine
- Vol. 27 (3) , 237-238
The Bilateral Selective Neurectomy for Bilateral Synkinesis
- Open Access
- 19 March 2025
- Published by Wiley in Otolaryngology–Head and Neck Surgery
- Vol. 172 (6) , 1911-1918
Disclosure of Industry Relationships by Otolaryngologists
Objective: This study aims to characterize how often otolaryngologists disclose relevant industry payments in publications and identify characteristics of these industry relationships.Study Design: A cross‐sectional database and bibliometric analysis.Setting: Open Payments Database and PubMed.Methods: Publications by the 10 highest‐compensated otolaryngologists from each of 12 representative medical device and drug companies from 2018 to 2020 were assessed for disclosure of potential conflicts of interest in the years following payment through 2023.Results: After excluding 52 physicians who did not publish in this period, 102 individuals received a combined $8,473,091.68, with an individual median of 15 payments (interquartile range [IQR] = 47) and median compensation of $18,522.77 (IQR = $53,965.52) from 1 or more of the 12 companies analyzed. The median number of publications per author was 10 (IQR = 25), and the median h‐index of the authors was 16 (IQR = 28). Of the 1735 publications, 114 were classified as relevant, either because the study involved the evaluation of a device manufactured by one of the analyzed companies or because one of the companies funded the study. Of these, 23 (20.1%) were missing personal disclosure by the author. Of the physicians analyzed, the most represented subspecialty was rhinology (n = 47, 31%) followed by otology (n = 18, 11.8%).Conclusion: Although most publications in the years following payments from device companies were not deemed to have potential conflicts of interest, a notable proportion of those with authors who received payments lacked relevant financial disclosure. As transparency of relevant industry relationships has received increased attention, appropriate disclosure is recommended.
- 19 March 2025
- Published by Wiley in Otolaryngology–Head and Neck Surgery
- Vol. 172 (6) , 1911-1918
Open AccessDisclosure of Industry Relationships by Otolaryngologists
Objective: This study aims to characterize how often otolaryngologists disclose relevant industry payments in publications and identify characteristics of these industry relationships.Study Design: A cross‐sectional database and bibliometric analysis.Setting: Open Payments Database and PubMed.Methods: Publications by the 10 highest‐compensated otolaryngologists from each of 12 representative medical device and drug companies from 2018 to 2020 were assessed for disclosure of potential conflicts of interest in the years following payment through 2023.Results: After excluding 52 physicians who did not publish in this period, 102 individuals received a combined $8,473,091.68, with an individual median of 15 payments (interquartile range [IQR] = 47) and median compensation of $18,522.77 (IQR = $53,965.52) from 1 or more of the 12 companies analyzed. The median number of publications per author was 10 (IQR = 25), and the median h‐index of the authors was 16 (IQR = 28). Of the 1735 publications, 114 were classified as relevant, either because the study involved the evaluation of a device manufactured by one of the analyzed companies or because one of the companies funded the study. Of these, 23 (20.1%) were missing personal disclosure by the author. Of the physicians analyzed, the most represented subspecialty was rhinology (n = 47, 31%) followed by otology (n = 18, 11.8%).Conclusion: Although most publications in the years following payments from device companies were not deemed to have potential conflicts of interest, a notable proportion of those with authors who received payments lacked relevant financial disclosure. As transparency of relevant industry relationships has received increased attention, appropriate disclosure is recommended.
- 1 March 2025
- Published by SAGE Publications in Facial Plastic Surgery & Aesthetic Medicine
- Vol. 27 (2) , 143-144
Invited Commentary on: “Selective Neurectomy with Regenerative Peripheral Nerve Interface Surgery for Facial Synkinesis,” by Gu et al
- 1 March 2025
- Published by SAGE Publications in Facial Plastic Surgery & Aesthetic Medicine
- Vol. 27 (2) , 143-144
Invited Commentary on: “Selective Neurectomy with Regenerative Peripheral Nerve Interface Surgery for Facial Synkinesis,” by Gu et al
- 1 February 2025
- Published by SAGE Publications in Facial Plastic Surgery & Aesthetic Medicine
- Vol. 27 (1) , 1-2
Are Tear Trough Fillers Really that Bad?
- 1 February 2025
- Published by SAGE Publications in Facial Plastic Surgery & Aesthetic Medicine
- Vol. 27 (1) , 1-2
Are Tear Trough Fillers Really that Bad?
- Open Access
- 30 January 2025
- Published by SAGE Publications in American Journal of Rhinology & Allergy
- Vol. 39 (3) , 205-210
Trends in Dupilumab-Related Payments to Physicians Across Five Specialties
Background: Dupilumab was first approved by the United States Food and Drug Administration in 2017 for atopic dermatitis and has since been approved for many other indications. The use of dupilumab has grown, but industry payments to physicians have yet to be explored. Objective: The study objective is to characterize the change in payments by pharmaceutical companies to physicians for dupilumab-related promotional activities. Methods: Data from 2017 to 2023 was extracted from the Open Payments website and filtered to determine the number of dupilumab-related payments to physicians, the amounts of these payments, the number of unique physicians that were paid, and the amount of money going towards different payment purposes. Results: In 2017, pharmaceutical companies paid a total of $6.1 million to allergists/immunologists, dermatologists, gastroenterologists, otolaryngologists, and pulmonologists for dupilumab-related activities. This amount grew to a total of $22.6 million in 2023. These specialties all experienced an increase in the number of unique physicians paid; the number of allergists/immunologists paid increased by 1.8-fold, dermatologists by 1.4-fold, gastroenterologists by 640-fold, otolaryngologists by 95-fold, and pulmonologists by 118-fold. Across all five specialties, pharmaceutical companies paid the most money for the purpose of non-consulting, non-continuing education speaker fees. Conclusion: From 2017 to 2023, pharmaceutical companies have paid increasing numbers of payments to increasing numbers of unique allergists/immunologists, dermatologists, gastroenterologists, otolaryngologists, and pulmonologists for dupilumab-related promotional events.
- 30 January 2025
- Published by SAGE Publications in American Journal of Rhinology & Allergy
- Vol. 39 (3) , 205-210
Open AccessTrends in Dupilumab-Related Payments to Physicians Across Five Specialties
Background: Dupilumab was first approved by the United States Food and Drug Administration in 2017 for atopic dermatitis and has since been approved for many other indications. The use of dupilumab has grown, but industry payments to physicians have yet to be explored. Objective: The study objective is to characterize the change in payments by pharmaceutical companies to physicians for dupilumab-related promotional activities. Methods: Data from 2017 to 2023 was extracted from the Open Payments website and filtered to determine the number of dupilumab-related payments to physicians, the amounts of these payments, the number of unique physicians that were paid, and the amount of money going towards different payment purposes. Results: In 2017, pharmaceutical companies paid a total of $6.1 million to allergists/immunologists, dermatologists, gastroenterologists, otolaryngologists, and pulmonologists for dupilumab-related activities. This amount grew to a total of $22.6 million in 2023. These specialties all experienced an increase in the number of unique physicians paid; the number of allergists/immunologists paid increased by 1.8-fold, dermatologists by 1.4-fold, gastroenterologists by 640-fold, otolaryngologists by 95-fold, and pulmonologists by 118-fold. Across all five specialties, pharmaceutical companies paid the most money for the purpose of non-consulting, non-continuing education speaker fees. Conclusion: From 2017 to 2023, pharmaceutical companies have paid increasing numbers of payments to increasing numbers of unique allergists/immunologists, dermatologists, gastroenterologists, otolaryngologists, and pulmonologists for dupilumab-related promotional events.
- 28 December 2024
- Published by Wiley in The Laryngoscope
- Vol. 135 (6) , 1975-1982
Repositioning the Posterior Septal Angle in Rhinoplasty: Methods and Outcomes
Objective: Repositioning and fixation of the posterior septal angle (PSA) relative to the anterior nasal spine (ANS) is a well‐known maneuver performed during rhinoplasty. Suture techniques through the periosteum along with transosseous drilling through the spine are the two most common fixation methods. We report on how nasal airway patency varies as a function of technique and patient demographic factors.Methods: A retrospective analysis was performed on patients who underwent PSA repositioning and stabilization during rhinoplasty due to caudal septal deformities. Nasal Obstruction Symptom Evaluation (NOSE) scales were measured pre‐ and post‐operation to evaluate functional outcomes.Results: 207 patients with either mobile or immobile PSA underwent ANS fixation secured with either a suture passed through the periosteum of the ANS or with the creation of a drill hole through the ANS. In all patients regardless of clinical or demographic groupings, postoperative NOSE scores were significantly decreased when compared to preoperative scores (p < 0.05). Preoperative NOSE score, fixation method, sex, functional versus cosmetic, age, follow‐up period, and graft site did not independently affect the postoperative NOSE score. Though the differences between primary and revision outcomes were statistically significant, patients in both groups reported significant improvements in postoperative NOSE scores that deescalated their symptoms from “severe” to “mild.”Conclusion: Repositioning and fixation of the PSA improve patient outcomes. However, there is no significant difference between fixation methods on final NOSE scores. Septal fixation with consideration for patient anatomy allows for effective treatment.Level of Evidence: 4 Laryngoscope, 135:1975–1982, 2025
- 28 December 2024
- Published by Wiley in The Laryngoscope
- Vol. 135 (6) , 1975-1982
Repositioning the Posterior Septal Angle in Rhinoplasty: Methods and Outcomes
Objective: Repositioning and fixation of the posterior septal angle (PSA) relative to the anterior nasal spine (ANS) is a well‐known maneuver performed during rhinoplasty. Suture techniques through the periosteum along with transosseous drilling through the spine are the two most common fixation methods. We report on how nasal airway patency varies as a function of technique and patient demographic factors.Methods: A retrospective analysis was performed on patients who underwent PSA repositioning and stabilization during rhinoplasty due to caudal septal deformities. Nasal Obstruction Symptom Evaluation (NOSE) scales were measured pre‐ and post‐operation to evaluate functional outcomes.Results: 207 patients with either mobile or immobile PSA underwent ANS fixation secured with either a suture passed through the periosteum of the ANS or with the creation of a drill hole through the ANS. In all patients regardless of clinical or demographic groupings, postoperative NOSE scores were significantly decreased when compared to preoperative scores (p < 0.05). Preoperative NOSE score, fixation method, sex, functional versus cosmetic, age, follow‐up period, and graft site did not independently affect the postoperative NOSE score. Though the differences between primary and revision outcomes were statistically significant, patients in both groups reported significant improvements in postoperative NOSE scores that deescalated their symptoms from “severe” to “mild.”Conclusion: Repositioning and fixation of the PSA improve patient outcomes. However, there is no significant difference between fixation methods on final NOSE scores. Septal fixation with consideration for patient anatomy allows for effective treatment.Level of Evidence: 4 Laryngoscope, 135:1975–1982, 2025
- 26 December 2024
- Published by Wiley in The Laryngoscope
- Vol. 135 (6) , 1983-1988
Nasal Obstruction Outcomes in Medial Flap Turbinoplasty and Inferior Turbinate Submucous Resection
Objectives: To compare longitudinal improvement in nasal obstruction quality‐of‐life outcomes between medial flap turbinoplasty (MFT) and inferior turbinate submucous resection (SMR) concurrently performed with functional septorhinoplasty.Methods: Retrospective review of a prospectively collected cohort of patients undergoing functional septorhinoplasty between 2015 and 2022 at a tertiary academic center. Outcomes were assessed using the Nasal Obstruction Symptom Evaluation (NOSE) questionnaire preoperatively and over 12 months postoperatively.Results: 373 patients were analyzed with longitudinal NOSE questionnaires. Of these, 298 underwent SMR and 75 underwent MFT. The proportion of concurrent intraoperative techniques including rim graft, spreader graft, auto‐spreader graft, intradomal sutures, interdomal sutures, and alar spanning sutures were not significantly different between the two cohorts. Patients in all surgical groups had a statistically and clinically significant improvement in NOSE scores between their preoperative and postoperative follow‐up visits (p < 0.001). MFT patients had higher NOSE scores 1 month postoperatively (40.0 ± 30.5 vs. 31.0 ± 27.97; p = 0.017), but lower scores after 10 months (15.2 ± 13.3 vs. 25.4 ± 23.5; p = 0.036). Similarly, patients in the MFT cohort in primary rhinoplasty procedures reported higher scores initially but lower after 10 months (p = 0.024). Men in the MFT cohort reported significantly better NOSE outcomes than the SMR cohort as early as 4 months post‐surgery and sustained this improvement longitudinally throughout the follow‐up period (10.6 ± 12.3 vs. 22.6 ± 21.4; p = 0.012).Conclusion: MFT and SMR offer beneficial long‐term nasal breathing outcomes among patients undergoing functional rhinoplasty, though further study in appropriate patient selection is indicated.Level of Evidence: 3 Laryngoscope, 135:1983–1988, 2025
- 26 December 2024
- Published by Wiley in The Laryngoscope
- Vol. 135 (6) , 1983-1988
Nasal Obstruction Outcomes in Medial Flap Turbinoplasty and Inferior Turbinate Submucous Resection
Objectives: To compare longitudinal improvement in nasal obstruction quality‐of‐life outcomes between medial flap turbinoplasty (MFT) and inferior turbinate submucous resection (SMR) concurrently performed with functional septorhinoplasty.Methods: Retrospective review of a prospectively collected cohort of patients undergoing functional septorhinoplasty between 2015 and 2022 at a tertiary academic center. Outcomes were assessed using the Nasal Obstruction Symptom Evaluation (NOSE) questionnaire preoperatively and over 12 months postoperatively.Results: 373 patients were analyzed with longitudinal NOSE questionnaires. Of these, 298 underwent SMR and 75 underwent MFT. The proportion of concurrent intraoperative techniques including rim graft, spreader graft, auto‐spreader graft, intradomal sutures, interdomal sutures, and alar spanning sutures were not significantly different between the two cohorts. Patients in all surgical groups had a statistically and clinically significant improvement in NOSE scores between their preoperative and postoperative follow‐up visits (p < 0.001). MFT patients had higher NOSE scores 1 month postoperatively (40.0 ± 30.5 vs. 31.0 ± 27.97; p = 0.017), but lower scores after 10 months (15.2 ± 13.3 vs. 25.4 ± 23.5; p = 0.036). Similarly, patients in the MFT cohort in primary rhinoplasty procedures reported higher scores initially but lower after 10 months (p = 0.024). Men in the MFT cohort reported significantly better NOSE outcomes than the SMR cohort as early as 4 months post‐surgery and sustained this improvement longitudinally throughout the follow‐up period (10.6 ± 12.3 vs. 22.6 ± 21.4; p = 0.012).Conclusion: MFT and SMR offer beneficial long‐term nasal breathing outcomes among patients undergoing functional rhinoplasty, though further study in appropriate patient selection is indicated.Level of Evidence: 3 Laryngoscope, 135:1983–1988, 2025
- Open Access
- 26 November 2024
- Published by Wiley in Otolaryngology–Head and Neck Surgery
- Vol. 172 (3) , 888-896
Understanding the Composition of a Comprehensive Otolaryngologist's Practice Through Medicare Reimbursements
Objective: With a rising number of otolaryngology (ORL) graduates completing a fellowship, the number of generalists (also known as comprehensive ORLs [c‐ORLs]), arguably the group of ORLs most needed, is likely to decrease. However, the practice and reimbursement patterns of c‐ORLs have yet to be examined.Study Design: Cross‐sectional retrospective analysis.Setting: 2019 Medicare Provider Utilization and Payment Datasets.Methods: All ORLs were isolated (n = 8959), and then a random 10% sample was obtained. These 897 ORLs were queried for fellowship completion, isolating out those who have not completed a fellowship, and characterizing their practice patterns with regards to Medicare, the largest insurer in the US.Results: Within the random sample, 554 (61.8%) were c‐ORLs, of which 47 (8.5%) practiced in an academic setting. c‐ORLs billed a mean of 52.9 (SD: 26.6) Current Procedural Terminology (CPT), and community‐based c‐ORLs had a more diverse practice (P < .001). On average, Medicare paid $138,942 ($117,563) to each c‐ORL for 1982.2 (2614.7) services for 451.7 (296.9) patients. Ninety‐five percent of their total reimbursements were office‐based. Of 250 unique CPT codes billed, 52.8% of all c‐ORLs reimbursements were from evaluation and management services, 17.8% from rhinology, 9.7% from otology/neurotology, and 9% from laryngology.Conclusion: Though surgery is an integral aspect of all ORLs' training and practice, c‐ORLs practice in a largely office‐based setting, at least with regard to Medicare patients. While c‐ORLs clearly practice with a diverse skill set, their reimbursement patterns suggest rhinology makes up the largest proportion of their procedural practice.
- 26 November 2024
- Published by Wiley in Otolaryngology–Head and Neck Surgery
- Vol. 172 (3) , 888-896
Open AccessUnderstanding the Composition of a Comprehensive Otolaryngologist's Practice Through Medicare Reimbursements
Objective: With a rising number of otolaryngology (ORL) graduates completing a fellowship, the number of generalists (also known as comprehensive ORLs [c‐ORLs]), arguably the group of ORLs most needed, is likely to decrease. However, the practice and reimbursement patterns of c‐ORLs have yet to be examined.Study Design: Cross‐sectional retrospective analysis.Setting: 2019 Medicare Provider Utilization and Payment Datasets.Methods: All ORLs were isolated (n = 8959), and then a random 10% sample was obtained. These 897 ORLs were queried for fellowship completion, isolating out those who have not completed a fellowship, and characterizing their practice patterns with regards to Medicare, the largest insurer in the US.Results: Within the random sample, 554 (61.8%) were c‐ORLs, of which 47 (8.5%) practiced in an academic setting. c‐ORLs billed a mean of 52.9 (SD: 26.6) Current Procedural Terminology (CPT), and community‐based c‐ORLs had a more diverse practice (P < .001). On average, Medicare paid $138,942 ($117,563) to each c‐ORL for 1982.2 (2614.7) services for 451.7 (296.9) patients. Ninety‐five percent of their total reimbursements were office‐based. Of 250 unique CPT codes billed, 52.8% of all c‐ORLs reimbursements were from evaluation and management services, 17.8% from rhinology, 9.7% from otology/neurotology, and 9% from laryngology.Conclusion: Though surgery is an integral aspect of all ORLs' training and practice, c‐ORLs practice in a largely office‐based setting, at least with regard to Medicare patients. While c‐ORLs clearly practice with a diverse skill set, their reimbursement patterns suggest rhinology makes up the largest proportion of their procedural practice.